Behr J / Günther A |
Diffuse Parenchymal Lung Disease (DPLD) |
all |
Exploratory efficacy and safety study of oral pirfenidone for progressive, non-IPF lung fibrosis (RELIEF in lung fibrosis) |
Griese M |
Diffuse Parenchymal Lung Disease (DPLD) |
all |
Hydroxychloroquine (HCQ) in pediatric ILD (= children‘s interstitial lung disease; chILD) |
Herold S |
Pneumonia and Acute Lung Injury |
BREATH, UGMLC |
GM-CSF Inhalation to improve HOst defense and Pulmonary barrier rEsoration (GI-HOPE) |
Herold S / Lohmeyer J / Welte T |
Pneumonia and Acute Lung Injury |
BREATH, UGMLC |
Promotion of host defense and alveolar barrier regeneration by inhaled GM-CSF in patients with pneumonia-associated ARDS |
Heußel C |
Lung Cancer |
BREATH, CPC-M, TLRC, UGMLC |
Early response capturing in the treatment of adenocarcinoma |
Jobst B |
COPD |
all |
Imaging disease progression in COP |
Kreuter M / Vogelmeier C / Herth F |
COPD |
TLRC, UGMLC |
Exploring efficacy of peridontal treatment on systemic inflammation and for prevention of exacerbations in patients with COPD: A multi-center, prospective, randomized, controlled, parallel-group pilot study |
Reck M / Ammerpohl O / Barreto G |
Lung Cancer |
all |
Monitoring of patients with NLCLC – epigenetic analysis of liquid biopsies and RNA-analysis in exhaled breath condensates |
Schulz H / Meiners S / Vogelmeier C / Behr J |
COPD |
CPC-M, UGMLC |
Proteasom Function as a Bio-Marker for COPD |
Seeger W / Ghofrani A / Gall H |
Pulmonary Hypertension |
BREATH, UGMLC |
Influence of specific PAH medication on right ventricular function in patients with pulmonary arterial hypertension |
Tümmler B |
Cystic Fibrosis / Mucoviscidosis |
BREATH, TLRC, UGMLC |
Orkambifacts – Intestinal current measurements (ICM) to evaluate the activation of mutant CFTR in treated with lumacaftor in combination with ivacaftor. |
Vogel-Claussen J |
Radiology / Pulmonale Hypertronie |
BREATH, CPC-M, UGMLC, TLRC |
Change-MRI – Phase III diagnostic trial to demonstrate that functional lung MRI can replace VQ-SPECT in a diagnostic strategy for patients with suspected CTEPH. |
Vogelmeier C |
COPD |
ARCN, BREATH, UGMLC |
Clinical study to investigate safety, tolerability, efficacy, pharmacokinetics and pharmacodynamics of multiple doses of the human GATA-3-specific DNAzyme solution SB010 in patients with moderate to severe COPD – A randomised, double-blind, parallel, multicentre, phase IIa pilot study |
Zabel P / Herth F / König I / Rabe K / Welte T |
COPD |
ARCN, BREATH, TLRC |
Evaluation of non-invasive pursed-lip breathing ventilation in advanced COPD |